We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+6.06%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$232M
AUM Growth
+$50.9M
(+28%)
Cap. Flow
+$44.7M
Cap. Flow
% of AUM
19.23%
Top 10 Holdings %
Top 10 Hldgs %
11.45%
Holding
739
New
281
Increased
160
Reduced
94
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$2.84M |
| 2 |
FYBR
Frontier Communications
FYBR
|
+$2.67M |
| 3 |
Coca-Cola
KO
|
+$2.56M |
| 4 |
Netflix
NFLX
|
+$2.19M |
| 5 |
Roper Technologies
ROP
|
+$2.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$3.51M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$2.19M |
| 3 |
Gartner
IT
|
+$2.16M |
| 4 |
Palantir
PLTR
|
+$2.1M |
| 5 |
Take-Two Interactive
TTWO
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.33% |
| 2 | Technology | 18.29% |
| 3 | Industrials | 15.96% |
| 4 | Healthcare | 11.31% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Companhia Siderúrgica Nacional
SID
$1.45B
| $43.2K | 0.02% |
28,789
+12,421
| +76% | +$17.9K |
|
502
ImmunityBio
IBRX
$7.87B
| $43K | 0.02% |
+17,470
| New | +$45K |
|
|
NFGC
503
New Found Gold
NFGC
$565M
| $42.8K | 0.02% |
18,072
+7,222
| +67% | +$12.7K |
|
504
Gevo
GEVO
$426M
| $42.6K | 0.02% |
21,711
-7,601
| -26% | -$12.4K |
|
505
Community Health Systems
CYH
$454M
| $40K | 0.02% |
+12,470
| New | +$37.4K |
|
506
C4 Therapeutics
CCCC
$414M
| $39.7K | 0.02% |
17,880
-12,707
| -42% | -$30.5K |
|
507
Phunware
PHUN
$44.6M
| $39.5K | 0.02% |
14,359
+2,171
| +18% | +$6.25K |
|
508
SunPower Inc
SPWR
$99M
| $39.1K | 0.02% |
+22,195
| New | +$36.7K |
|
509
GSI Technology
GSIT
$238M
| $38.3K | 0.02% |
+10,421
| New | +$39.3K |
|
510
Fossil Group
FOSL
$246M
| $37.9K | 0.02% |
14,729
+1,299
| +10% | +$3.07K |
|
511
Zevia
ZVIA
$111M
| $36.4K | 0.02% |
+13,385
| New | +$38.5K |
|
512
Rackspace Technology
RXT
$1.05B
| $35.4K | 0.02% |
25,127
+10,707
| +74% | +$14.3K |
|
513
Iovance Biotherapeutics
IOVA
$2.31B
| $34.8K | 0.02% |
16,043
+4,700
| +41% | +$11.1K |
|
514
TScan Therapeutics
TCRX
$58.8M
| $34.3K | 0.01% |
18,827
+7,646
| +68% | +$13.5K |
|
|
NXDR
515
Nextdoor Holdings
NXDR
$885M
| $32.9K | 0.01% |
+15,738
| New | +$30.5K |
|
516
Purple Innovation
PRPL
$29.7M
| $32.6K | 0.01% |
+1,395
| New | +$32.6K |
|
|
ESPR
517
DELISTED
Esperion Therapeutics
ESPR
| $32.5K | 0.01% |
+12,283
| New | +$23.8K |
|
518
Blink Charging
BLNK
$79.5M
| $31.5K | 0.01% |
+19,204
| New | +$21.3K |
|
519
Neuronetics
STIM
$134M
| $30.7K | 0.01% |
11,257
-3,766
| -25% | -$13.4K |
|
520
Baytex Energy
BTE
$3.06B
| $30.6K | 0.01% |
+13,077
| New | +$28K |
|
521
Caribou Biosciences
CRBU
$165M
| $28.6K | 0.01% |
+12,268
| New | +$23.2K |
|
|
OPTU
522
Optimum Communications Inc
OPTU
$350M
| $24.8K | 0.01% |
10,273
-3,588
| -26% | -$8.8K |
|
523
Neumora Therapeutics
NMRA
$285M
| $24.4K | 0.01% |
13,381
-11,682
| -47% | -$18.9K |
|
524
Pulmonx
LUNG
$51.1M
| $23.8K | 0.01% |
14,683
-1,328
| -8% | -$2.78K |
|
525
Fate Therapeutics
FATE
$301M
| $22.6K | 0.01% |
+17,929
| New | +$19.3K |
|
Similar funds
NED
CFG
CFG
WCM
TFP
AFS
EMB
TCPG
R Squared's Q3 2025 Portfolio in Review
As of Q3 2025, R Squared held 739 positions worth $232M, up 28% from $181M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
R Squared deployed $44.7M of net new capital in Q3 2025, opening 281 new positions and adding to 160 existing holdings. Its largest new stake was Honeywell: 13,607 shares worth $2.7M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was McDonald's, an estimated $3.51M trimmed.
- R Squared's largest Q3 2025 buy was Honeywell: 13,607 shares worth $2.7M.
- R Squared added most to Frontier Communications in Q3 2025, an estimated $2.67M increase.
- R Squared's biggest Q3 2025 reduction was McDonald's, cutting an estimated $3.51M.
- R Squared fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $2.19M.
- R Squared's ten largest holdings make up 11% of its $232M portfolio in Q3 2025.
- R Squared opened 281 new positions and closed 202 in Q3 2025.
- R Squared's portfolio value rose 28% quarter-over-quarter to $232M.
Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.